Company Overview and News

 
Ex-Hawkins Orange-H placed in receivership by shareholder; owes creditors $30 million

2018-05-11 nzherald.co.nz
Orange-H Group, the McConnell entity set up to run down the residual Hawkins assets after the sale to Downer Group, has been tipped into receivership by its shareholder and creditor just 10 days after being ordered to pay $13.4 million over a leaky school.

 
OZ closes Prominent Hill open pit

2018-04-17 australianmining.com.au
OZ Minerals has completed its planned closure of the Prominent Hill open pit in South Australia.

 
OZ Minerals awards $660m Carrapateena contract to Downer

2018-04-16 australianmining.com.au
Downer EDI will deliver underground mining services at OZ Minerals’ Carrapateena copper-gold project in South Australia after being awarded a $660 million contract at the operation.

 
New Century awards ‘landmark’ training contract at Century mine

2018-03-28 australianmining.com.au
New Century Resources has awarded what has been described as a landmark contract to the Waanyi ReGen Joint Venture (WRJV) to provide training services for Aboriginal and Torres Strait Islander people local to the Century zinc mine in Queensland.

 
CIMIC joins BHP, Rio on LinkedIn top companies list

2018-03-21 australianmining.com.au
CIMIC Group is the first of several mining and related services companies that have been named in LinkedIn’s 2018 Top Companies list for Australia.

 
Downer secures $600m contract at BMA coal mine

2018-02-28 australianmining.com.au
Downer EDI has been awarded a $600 million contract to provide mining and related services at BHP Billiton Mitsubishi Alliance’s (BMA) Blackwater coal mine in Queensland.

 
Big investors backed shareholder campaigns on climate, human rights

2018-02-23 smh.com.au
It had already been a challenging year for BHP by the time its new chairman, Ken MacKenzie, took to the stage at the company's AGM last November.

 
Adani may sell stake in Australia’s Carmichael coal mine amid funding delay

2018-02-22 livemint
Sydney: The battle to build one of the world’s biggest coal mines has suffered a fresh setback after Adani Enterprises Ltd conceded it would fail to meet a March deadline to arrange A$3 billion ($2.3 billion) in financing for the project.

 
Downer EDI, Ltd. ADR 2018 Q2 - Results - Earnings Call Slides

2018-02-21 seekingalpha
The following slide deck was published by Downer EDI, Ltd. ADR in conjunction with their 2018 Q2 earnings call.

 
Downer makes $11.1m loss on impairments

2018-02-21 businessnews.com.au
Downer EDI has posted an $11.1 million first-half loss dragged down by a goodwill impairment on its mining operations, writedowns from its freight rail divestment and redundancy costs from its recently acquired Spotless.

 
Downer makes $11.1m loss on impairments

2018-02-21 perthnow.com.au
Downer EDI has posted an $11.1 million first-half loss dragged down by a goodwill impairment on its mining operations, writedowns from its freight rail divestment and redundancy costs from its recently acquired Spotless.

 
Walmart pulls down Wall Street, Dow drops 300 points

2018-02-20 abc.net.au
Two signs are pointing to a lower open for the ASX today — Wall Street's lacklustre overnight performance and BHP's plunge in overseas markets.

 
Downer flags $77m goodwill impairment hit

2018-02-05 businessnews.com.au
Downer EDI has flagged a goodwill impairment charge of $77 million on its mining operations after failing to renew two material contracts and delays in securing alternative business.

 
No federal financing for Adani's Carmichael rail line: Australian official

2018-02-04 business-standard
There will be no Australian federal financing of a loan facility for Indian conglomerate Adani Enterprises Ltd to build a rail line to its proposed Carmichael coal project, a government frontbencher confirmed on Sunday.

 
Australian official confirms no federal financing for Adani mine

2018-02-04 in.reuters
SYDNEY (Reuters) - There will be no Australian federal financing of a loan facility for Indian conglomerate Adani Enterprises Ltd to build a rail line to its proposed Carmichael coal project, a government frontbencher confirmed on Sunday.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...